Abstract | BACKGROUND: METHODS: Male Sprague-Dawley rats (n=13 per group) were traumatised and exsanguinated until a MAP of 40 mm Hg was reached, then randomised to two groups: red blood cells, plasma and platelets in a 1:1:1 ratio with either bosutinib or vehicle. Controls were randomised to sham (median laparotomy, no trauma) with bosutinib or vehicle. Organs were harvested for histology and wet/dry (W/D) weight ratio. RESULTS: Traumatic injury resulted in shock, with higher lactate levels compared with controls. In trauma-induced shock, the resuscitation volume needed to obtain a MAP of 60 mm Hg was lower in bosutinib-treated animals (2.8 [2.7-3.2] ml kg-1) compared with vehicle (6.1 [5.1-7.2] ml kg-1, P<0.001). Lactate levels in the bosutinib group were 2.9 [1.7-4.8] mM compared with 6.2 [3.1-14.1] mM in the vehicle group (P=0.06). Bosutinib compared with vehicle reduced lung vascular leakage (W/D ratio of 5.1 [4.6-5.3] vs 5.7 [5.4-6.0] (P=0.046) and lung injury scores (P=0.027). CONCLUSIONS:
|
Authors | Derek J B Kleinveld, Liza Botros, M Adrie W Maas, Jesper Kers, Jurjan Aman, Markus W Hollmann, Nicole P Juffermans |
Journal | British journal of anaesthesia
(Br J Anaesth)
Vol. 126
Issue 5
Pg. 958-966
(May 2021)
ISSN: 1471-6771 [Electronic] England |
PMID | 33685634
(Publication Type: Journal Article)
|
Copyright | Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved. |
Chemical References |
- Aniline Compounds
- Nitriles
- Protein Kinase Inhibitors
- Quinolines
- Lactic Acid
- bosutinib
|
Topics |
- Aniline Compounds
(pharmacology)
- Animals
- Blood Transfusion
(methods)
- Disease Models, Animal
- Endothelium, Vascular
(metabolism, pathology)
- Lactic Acid
(metabolism)
- Lung Injury
(drug therapy, etiology)
- Male
- Multiple Trauma
(complications, drug therapy, physiopathology)
- Nitriles
(pharmacology)
- Permeability
(drug effects)
- Protein Kinase Inhibitors
(pharmacology)
- Quinolines
(pharmacology)
- Random Allocation
- Rats
- Rats, Sprague-Dawley
- Resuscitation
(methods)
- Shock
(drug therapy, etiology)
|